The preclinical study provides evidence for strongly improved immune responses with second-generation mRNA backbone jointly developed by CureVac and GSK compared to CureVac’s first-generation mRNA backbone
The funds will be used to buy medicines, enhance oxygen supply and augment the bed capacity in the local and district level hospitals
Through the Sehat Sathi App business can access unsecured business loans at low interest
It strengthens its presence to over 250 stores
Rs one crore for each district to create medicine pool and support Centre of Excellence for Telemedicine
The data suggest that a booster dose given within 6 to 12 months after the second dose may help maintain a high level of protection against COVID-19.
The project is a collaboration between IIT Delhi and AIIMS
The acquisition will provide it with a foothold in the US $ 48 billion global animal health market
A treatment to prevent extreme symptoms and cut hospitalisation
Asia-Pacific is projected to portray the fastest CAGR of 13.2 by 2030
Subscribe To Our Newsletter & Stay Updated
